恢复STAR*D:在失败的SSRI治疗后,RIAT对药物增强疗法的重新分析,使用患者级数据,忠实于原始研究协议
Colin Xu1, Thomas T Kim2, Martin Plöderl3
1Department of Psychology & Communication, University of Idaho.
medRxiv : the preprint server for health sciences
|November 24, 2025
概括
对STAR*D增强研究的重新分析发现,缓解率和持续益处低于之前报告的水平. 与布普罗皮安SR相比,布斯皮龙增强与较高的治疗出现的自杀念头 (TESI) 风险有关.
科学领域:
- 精神病学是一个精神病学.
- 临床药理学 临床药理学
- 治疗有效性研究 研究治疗有效性研究
背景情况:
- 缓解抑郁症的测序治疗替代方案 (STAR*D) 试验是关于抗抑郁药治疗策略的关键研究.
- 之前的分析表明,与STAR*D的协议有所差异,导致报告的缓解率较低,治疗后出现自杀意念 (TESI) 的高率.
- 对STAR*D的增强研究进行重新分析是必要的,以验证其结果.
研究的目的:
- 为了重新分析STAR*D增强数据集,比较citalopram增强与布洛普里昂SR或巴斯皮龙.
- 根据原始方案评估缓解率和持续缓解,并将其与公布的STAR*D发现进行比较.
- 评估每个增强策略的治疗出现的自杀念头 (TESI) 率.
主要方法:
- 重新分析了STAR*D患者级增强数据集.
- 遵守原始协议的分析计划.
- 包括相关的STAR*D出版物分析,如果该协议不是具体的.
主要成果:
- 在最初的分析中,有124名患者 (21.9%) 被不适当地纳入.
- 布洛SR (25.0%对29.7%) 和巴斯皮龙 (25.8%对30.1%) 的协议定义缓解率较低.
- 12个月后持续缓解率在4.9%至12.5%之间.
- 与布洛 SR (3.6%) 相比,巴斯皮龙 (13.9%) 的TESI率显著更高.
结论:
- 重新分析显示,缓解率膨胀,持续益处低于最初的STAR*D出版物报告的水平.
- 与布鲁波相比,布斯皮龙增强与TESI的风险显著增加有关.
- 这两种增强策略都可能提供比人们普遍理解的更少的急性和持续益处.
更多相关视频
相关概念视频
Drug Therapy
235
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
235
Antidepressant Drugs: MAOIs and Other Agents
776
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
776
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
168
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
168
Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
387
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
387


